MedPath

The effect of vitamin D3 on the obesity

Not Applicable
Conditions
drug induced obesity.
Use additional external cause code (Chapter XX), if desired, to identify drug.
Registration Number
IRCT2014122520430N1
Lead Sponsor
Ahvaz Unversity Of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
50
Inclusion Criteria

women with psychiatric disorder;20-55 years old;not pregnant;have not any medical illness;during consuming olanzapin have weight gain;her serum level of vitamin is normal range.
Exclusion criteria:women with medical illness;poly cystic ovarian and women that receive other drug that induced obesity.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Weight,BMI,Wrist,Hip,Wrist hip ratio. Timepoint: Befor and after intervention. Method of measurement: Befor and after intervention with Scales and meters.
Secondary Outcome Measures
NameTimeMethod
usea,Headache. Timepoint: Befor intervention. Method of measurement: During intervention repeatedly.
© Copyright 2025. All Rights Reserved by MedPath